Litcius/Paper detail

Tumor-targeted molybdenum disulfide@barium titanate core–shell nanomedicine for dual photothermal and chemotherapy of triple-negative breast cancer cells

Chandran Murugan, Hyoryong Lee, Sukho Park

2022Journal of Materials Chemistry B34 citationsDOI

Abstract

@BT CSNP exhibits high drug loading, better biocompatibility, and improved anticancer efficacy toward TNBC cells due to its dual therapeutic approach in a single system, which opens up a new approach for dual cancer therapy.

Topics & Concepts

Photothermal therapyMaterials scienceNanomedicineTriple-negative breast cancerCancer researchBarium titanateDNA damageMolybdenum disulfideBreast cancerCancerNanotechnologyNanoparticleDNAOptoelectronicsMedicineChemistryBiochemistryInternal medicineDielectricMetallurgyNanoplatforms for cancer theranosticsAdvanced biosensing and bioanalysis techniquesExtracellular vesicles in disease
Tumor-targeted molybdenum disulfide@barium titanate core–shell nanomedicine for dual photothermal and chemotherapy of triple-negative breast cancer cells | Litcius